![](https://cdn.sanity.io/images/0vv8moc6/mhe/b0ffec464d99203b60885c42c2744f3781d87416-640x380.png?fit=crop&auto=format)
J&J’s PAH Combination Tablet Moves Closer Toward Approval in Europe
Johnson & Johnson’s combination pulmonary arterial hypertension (PAH) tablet is one step closer to market authorization in the European Union (EU). The company announced late last month that the European Medicines Agency’s Committee for Medicinal …